Kerry Group Expands Portfolio With Wellmune Acquisition
22 Oct 2015 --- Kerry Group plc, the global taste and nutrition company, has acquired Wellmune from Biothera Inc., a natural food, beverage and supplement ingredient that is clinically proven to help strengthen the immune system.
“The combination of Biothera’s technology and Kerry’s leadership in R&D, nutritional science, and forward looking market insights, will advance the science of immune health and help create new and innovative food, beverages and supplements,” said Richard G. Mueller, Chief Executive Officer of Biothera. “Wellmune is a great fit for Kerry’s portfolio of science-based, nutritional ingredients.”
Albert McQuaid, Chief Technical Officer, Functional Ingredients & Actives, told FoodIngredientsFirst: “It is part of the Kerry Group strategy to continue to seek acquisitions that fit with its over focus, covering authentic taste, nutritional ingredients, emerging markets and foodservice. Wellmune fits with the Kerry brand as a nutritional technology that enhances the immune system and makes it less susceptible to infection.”
Wellmune is a 100% natural food, beverage, and supplement ingredient, that strengthens the immune system, making it easier for consumers to be well and stay well. Backed by more than 10 clinical studies, this proprietary yeast beta 1,3/1,6 glucan has regulatory approval in major markets around the world. Products with Wellmune are available in more than 60 countries. Wellmune is patented, Kosher, Halal, non-allergenic, GMO-free, gluten-free and Informed-Sport Certified.
